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1. INTRODUCTION 
We have reported a specific receptor site for 
human growth hormone (hGH) on liver mem- 
brane fractions from pregnant rabbits [I]. The 
hGH receptor has been solubilized with the non- 
ionic detergent Triton X-100, and its characteristics 
have been studied [2-41. However, little is known 
about its chemical composition and subunit struc- 
ture. 
In [5] a crosslinking of t2sI-insulin to its receptor 
was described using disuccinimidyl suberate 
(DSS), a new non-cleavable reagent for crosslink- 
ing. Under mild conditions DSS can react rapidly 
with free amino groups. This affinity crosslinking 
technique in combination with sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS- 
PAGE) revealed that the insulin receptor on rat 
adipocytes [6] or IM-9 lymphoblastic cells [7] is 
composed of insulin binding subunits. Similarly, 
t251-human chorionic gonadotropin (hCG) was 
covalently crosslinked to its receptor on rat testis 
[8], and the quaternary structure has been ana- 
lyzed. Thus, the crosslinking of an isotopically la- 
belled hormone to the receptor using the suc- 
cinimidyl ester proved to be very useful for study- 
ing receptor proteins. 
Here, we describe the crosslinking of t2sI-hGH 
to the hepatic receptor of pregnant rabbits and 
present an analysis of the complex. We show that 
the hGH receptor involves a binding subunit of 
IV, 59 000. 
2. MATERIALS AND METHODS 
2.1. Hormones and reagents 
Human growth hormone (HS 1652 C, 2.0 U/mg) 
was a gift from the National Pituitary Agency 
(NIAMDD, NIH). Radio-iodination of hGH was 
performed as in [3], and t251-hGH spec. act. was 
- 100 mCi/mg. Na 1251 was ,purchased from New 
England Nuclear (Boston MA). DSS was a product 
of Pierce Chemicals (Rockford IL). Poly(ethylene 
glycol) 6000 was purchased from Nakarai Chemi- 
cals (Tokyo). Sepharose 6B, protein-A-Sepharose 
CL-4B, and concanavalin A-Sepharose were ob- 
tained from Pharmacia (Uppsala). 
2.2. Preparation of membrane fractions 
Crude membrane fractions were prepared from 
the livers of pregnant rabbits (New Zealand White, 
25-29 days pregnant) as in [ 1,3]. The fractions 
were stored at -20°C until use. 
2.3. Crosslinking of1251-hGH to the membranes 
The crude membranes (l-2 mg protein/ml) 
were incubated with 5 nM (110 ng/ml) t251-hGH 
for 6 h at 20°C in 1.0 ml 50 mM Tris-HCl buffer 
(pH 7.4) containing 10mM MgCl2 and 0.1% 
bovine serum albumin (BSA). At the end of in 
cubation, 3 ml ice-cold Tris-HCl buffer was add- 
ed and the tubes centrifuged at 3000 x g for 
30 min at 4°C to separate bound 1251-hGH from 
unbound. The t251-hGH bound membranes were 
then washed twice with ice-cold Krebs-Ringer 
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phosphate (KRP) buffer and suspended in the 
buffer at 1 mg protein/ml. Then freshly prepared 
DSS (0.1 M in dimethyl sulfoxide) was added to 
make 1 mM final cont. as in [5]. Unless otherwise 
indicated, crosslinking was performed at 20°C for 
30 min, and was terminated by the addition of 
5 vol. ice-cold 10 mM Tris, 1 mM EDTA (pH 7.4). 
The mixture was centrifuged for 30 min at 
10000 x g and the pellet washed twice with ice- 
cold KRP buffer. The dissociation of t*51-hGH 
from DSS-treated t*sI-hGH-bound membranes 
was determined by the exposure of the membranes 
to an excess of unlabelled hGH (10 pg/ml), 
0.1 N HCl or 5.0 M urea. 
2.4. Solubilization and partial purification of IrJI- 
hGH crosslinked receptor 
t*5I-hGH crosslinked membranes were sol- 
ubilized for 60 min at 20°C in 50 mM Tris-HCl 
buffer (pH 7.4) containing 1% (v/v) Triton X-100, 
100 U bacitracin/ml and 500 U aprotinin/ml. Pro- 
tein concentrations were adjusted to l-2 mg/ml. 
The mixture was then centrifuged for 90 min at 
100 000 x g and the insoluble pellet was dis- 
carded. The supernatant was gel-filtered on a 
Sepharose 6B column (1.5 x 85 cm) at 10 ml/h at 
4°C to separate the t*sI-hGH:receptor complex 
from unbound t*sI-hGH. The fractions containing 
t*5I-hGH:receptor complex were pooled and sub- 
jected to an affinity chromatography on a con- 
canavalin A-Sepharose column (2 X 4 cm) pre- 
equilibrated with 50 mM Tris-HCl buffer 
(pH 7.4) containing 0.1% (v/v) Triton X-100 
(Tris-Triton buffer). The flow rate was adjusted to 
10 ml/h. The column was washed with Tris-Tri- 
ton buffer at 4°C until no radioactivity was eluted. 
Elution of the t*sI-hGH:receptor complex was 
achieved with 2 bed vol. of 0.3 M a-methyl-D- 
glucoside in Tris-Triton buffer at 4°C. 
2.5. Polyacrylamide gel electrophoresis 
t*5I-hGH crosslinked membranes were sol- 
ubilized by heating them at 100°C for 5 min in 
50 mM Tris-HCl buffer (pH 6.8) containing 10% 
(v/v) glycerol, 1% sodium dodecyl sulfate (SDS), 
and 100 mM dithiothreitol. After centrifugation at 
10 000 x g for 20 min, 50-100 ~1 supernatant 
(10 000-20 000 cpm) was applied to a 7.5% poly- 
acrylamide slab gel with a 3% stacking gel, and 
electrophoresed with the discontinuous buffer sys- 
50 
tern of 191. After staining the gels with 0.15% 
Coomassie blue dissolved in 50% trichloroacetic 
acid and then destaining them with 7% (v/v) acetic 
acid, they were sliced into 1 mm-thick slices and 
assayed for radioactivity in a gamma counter. Al- 
ternatively, the gels were dried and subjected to 
autoradiography. The M,-values of the standards 
are: lilamin (250 000); myosin (200 000); /?I and /32 
subunits of RNA polymerase (165 000 and 
155 000); phosphorylase B (94 000); bovine serum 
albumin (67 000); and ovalbumin (43 000). 
2.6. Immunoprecipitation of ‘25I-hGH:receptor 
complex 
An aliquot of the solubilized and partially pu- 
rified 1251-hGH:receptor complex was incubated 
for 18 h at 4°C with several dilutions of rabbit 
anti-hGH serum in 1 ml of 50 mM Tris-HCl buff- 
er (pH 7.4) containing 0.1% BSA and 0.1% (v/v) 
Triton X-100. Then 0.1 ml goat anti-rabbit IgG 
serum or 10 mg protein A-Sepharose CL4B was 
added and the tubes incubated a further 2 h at 
4°C. The mixture was centrifuged for 20 min at 
3000 x g and the radioactivity of the pellet was 
determined. 
3. RESULTS AND DISCUSSION 
DSS was found to be effective in crosslinking 
t*51-hGH to the membrane fractions of rabbit 
livers (table 1). After exposing t*sI-hGH bound 
membranes to 1 mM DSS for 30 min at 20°C the 
subsequent dissociation of t*51-hGH was strongly 
inhibited. Only 30% of the initially bound t*5I- 
hGH was dissociated by 0.1 N HCl from the DSS- 
treated 1251-hGH-bound membranes, while 90% 
was removed from the membranes not treated with 
DSS. The extent of crosslinking increased as a 
function of [DSS] (fig.l). Exposure to 1 mM DSS 
for 20-30 min was optimum. Under the condi- 
tions, ~50% of the membrane-bound t251-hGH 
was covalently crosslinked to its receptor as judged 
by the dissociability of **51-hGH when exposed to 
HCl or urea. If the membranes were incubated 
with 1251-hGH in the presence of an excess (10 pg/ 
ml) of unlabelled hGH, no appreciable crosslink- 
ing of t251-hGH was observed. 
The t*sI-hGH crosslinked membranes were sol- 
ubilized with 1% (v/v) Triton X-100 as in [3]. 
About 60% of the total membrane proteins and 
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Table 1 
Dissociation (W) of 12%hGH from liver membrane 
fractions 
Treatment Control DSS-treated 
hGH, 10 &ml 120 min 70 + 5 18 + 3 
at 30°C 
HCl, 0.1 N 10 min 88 + 2 29 f 4 
at 4°C 
Urea, 5.0 M 10 min 80 + 5 25 * 5 
at 4°C 
Membrane fractions were incubated with i251-hGH in 
the presence or absence of unlabelled hGH (10 pg/ml), 
washed, and then treated with 1 mM DSS for 30 min at 
20°C. For control, membranes were incubated with t25I- 
hGH in the same manner, but treated with dimethyl 
sulfoxide alone (final cont. 1%). The dissociation of t251- 
hGH from the treated membranes was tested by ex- 
posure to the agents indicated. t2sI-hGH associated 
membranes were incubated with an excess of unlabelled 
hGH in 1 ml 50 mM Tris-HCl buffer (pH 7.4) con- 
taining 0.1% BSA. Ice-cold Tris-HCl buffer (4 ml) was 
then added and the tubes centrifuged to separate the 
dissociated ‘IsI-hGH. Alternatively, membranes con- 
taining bound t251-hGH were exposed to HCl or urea 
for 10 min. After the addition of 5 vol. ice-cold Tris- 
HCl buffer, the membranes were separated by cen- 
trifugation. Dissociated t251-hGH was expressed as the 
percentages of the initially bound t2sI-hGH 
(the mean 2 SD of triplicate determinations) 
40% of the membrane-associated radioactivity 
were solubilized into the 100 000 x g supernatant. 
When an aliquot of the supernatant was subjected 
to gel-filtration on a Sepharose 6B column, 3 peaks 
of radioactivity appeared (fig. 2).The peak appear- 
ing in the void volume fractions (peak A) is most 
likely an aggregate of the **51-hGH:receptor com- 
plex. The second peak (peak B) appeared at the 
position corresponding to app. M, 200 000 and 
represents **51-hGH crosslinked to the receptor. 
Peak B (K,,. = 0.4) was largely eliminated when 
the membranes were incubated with t*51-hGH in 
the presence of an excess amount of unlabelled 
hGH (10 pg/ml) prior to crosslinking and solubil- 
ization. The third peak (peak C) migrated at a 
position corresponding to that of authentic t*51- 
hGH. 
r ’ ’ I I 
Concentration of DSS (mM) 
Fig. 1. Concentration dependence in crosslinking t2sI- 
hGH to membrane fractions of rabbit livers. tzsI-hGH 
bound membranes were treated with DSS at the indi- 
cated concentrations for 30 min at 20°C (0) or 4°C (0). 
Then the membranes were exposed to 0.1 N HCl for 
10 min as described in table 1. Values indicate the per- 
centage of initially bound t2sI-hGH not dissociated by 
HCl (the mean of duplicate determinations). 
When peak B fractions of Sepharose 6B column 
were pooled and applied to a concanavalin A- 
Sepharose column, - 80% of the radioactivity was 
adsorbed to the column, and a major part of the 
adsorbed counts could be dissociated by elution 
with 0.3 M cY-methyl-D-glucoside (not shown). The 
behavior of t251-hGH crosslinked receptor in both 
Sepharose 6B and concanavalin A-Sepharose col- 
umns is quite similar to that of its non-crosslinked 
counterpart [3], indicating that crosslinking using 
DSS does not cause gross changes in the Mr of the 
receptor or in its properties as a glycoprotein. 
We next tried to determine whether anti-hGH 
antibodies could bind to t*51-hGH which was 
covalently crosslinked to the receptor. A sol- 
ubilized t251-hGH:receptor complex was incu- 
bated with serial dilutions of rabbit anti-hGH 
serum and then with goat anti-rabbit IgG serum. It 
can be seen that anti-hGH serum precipitates the 
t251-hGH:receptor complex in a dose-dependent 
manner upon the addition of anti-rabbit IgG 
(tig.3). A similar result has been obtained with 
protein A-Sepharose instead of anti-rabbit IgG 
(not shown). Immunoprecipitation was strongly in- 
hibited by adding an excess amount of unlabelled 
hGH prior to the addition of anti-hGH, and nor- 
mal rabbit serum had no effect in precipitating the 
51 
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Fraction number 
Fig.2. Gel-filtration of solubilized t251-hGH crosslinked 
receptor. t251-hGH crosslinked membranes were sol- 
ubilized with 1% (v/v) Triton X-100 and centrifuged as 
described: 3 ml supernatant was gel-filtered on a 
Sepharose 6B column equilibrated with 50 mM Tris- 
HCl buffer (pH 7.4) containing 0.1% (v/v) Triton X-100. 
The 2 ml fractions were collected to determine radioac- 
tivity. The column had been calibrated with blue dex- 
tran 2000 (for void volume, V,); bovine thyroglobulin 
(M, 670 000) ferritin (440 000); catalase (232 000); BSA 
(67 000); ovalbumin (43 000); t251-hGH. and Nat251 (for 
total liquid volume. Vt). 
‘251-hGH:receptor complex. The binding of anti- 
hGH to the t*51-hGH:receptor complex indicates 
that crosslinking does not alter the immunological 
property of the hGH molecule. Crosslinking and 
immunoprecipitation may provide a useful meth- 
od for purifying the GH receptor as has been re- 
ported for the insulin receptor [lo]. 
t251-hGH crosslinked membranes were sol- 
ubilized, reduced and analyzed by SDS-PAGE. 
Generally, 3 peaks of radioactivity were detected 
as shown in fig. 4: (A) which barely entered the gel, 
may represent a high M,> 250 000) aggregate of 
the 125 I-hGH:receptor complex; (C) representing 
non-crosslinked 1251-hGH; (B) migrating to the 
position corresponding to M, 80 000 + 3000 (the 
mean + SD of 10 expt.) and was largely elimi- 
52 
Dilution of antiserum 
Fig.3. Immunoprecipitation of t25I-hGH:receptor com- 
plex; 3000 cpm of 1251-hGH:receptor complex was incu- 
bated with rabbit anti-hGH serum at the indicated final 
dilution in the presence (o) or absence (0) of 10 pg/ml 
unlabelled hGH. The t251-hGH:receptor complex had 
been partially purified by gel-filtration on a Sepharose 
6B column and by affinity chromatography on a con- 
canavalin A-Sepharose column as described in the text. 
Immunoprecipitation of the 1251-hGH:receptor complex 
was achieved by adding goat anti-rabbit IgG serum 
(0.1 ml). Radioactivity of the t251-hGH:receptor com- 
plex was completely precipitated with 12.5% 
poly(ethylene glycol) 6000, indicating the absence of 
free t251-hGH. Values are the mean of triplicate 
determinations. 
01 ’ I 1 I 
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Fig.4. SDS-PAGE of IzsI-hGH crosslinked mem- 
branes. ‘IsI-hGH bound membranes were treated with 
I mM DSS for 30 min at 20°C and subjected to SDS- 
PAGE. The samples were electrophoresed at 50 V in the 
stacking gel and 100 V in the separating gel. After stain- 
ing and subsequent destaining, the gel was sliced into 
I mm thick slices and assayed for radioactivity. 
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nated when membranes were incubated with 1251- 
hGH in the presence of 10 pg/ml unlabelled hGH 
or bovine GH, indicating specificity in the binding 
of t251-hGH to the component. Similar results 
have been obtained with autoradiography (not 
shown). Thus, analysis of t251-hGH crosslinked 
membranes revealed a complex with Mr 80 000. 
There was no significant alteration in the elec- 
trophoretic behavior of peak B in the absence of 
the dithiol reductant dithiothreitol (not shown). 
Therefore, it seems that the hGH binding compo- 
nent is not linked to other components by disullide 
bonds. Because hGH M, is - 21 000, the hGH 
binding component M, would be 59 000. An ap- 
parent Mr of the Triton-solubilized hepatic GH re- 
ceptor of pregnant rabbits has been estimated to 
be 300 000 [2] or 200 000 [3]. The receptor may be 
composed of M, 59 000 subunit non-covalently as- 
sociated with a non-identical component. Alter- 
natively, the receptor may be an oligomer of the 
M, 59 000 species forming a complex of app. 
M, 200 000. 
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